Home
Home About Us Our Technology News + Media Investor Relations Contact Us
 
Investor Info
SEC Filings

XBRL Filings
Governance Documents
 

Investor Relations



CytoSorbents Investor Materials



CytoSorbents Annual Shareholder Letter: CytoSorbents 2016 - Driving Towards the Inflection Point

CytoSorbents Investor Presentation - February 2016

CytoSorbents Q3 2015 Conference Call    -    November 13, 2015
Official Transcript                Presentation                Webcast

2015 Rodman & Renshaw Annual Global Investment Conference - September 10, 2015

CytoSorbents Q2 2015 Conference Call    -    August 13, 2015
Official Transcript                Presentation                Webcast

CytoSorbents Q1 2015 Conference Call    -    May 11, 2015
Official Transcript                Presentation                Webcast

CytoSorbents Annual Shareholder Letter - April 2015

CytoSorbents Year End 2014 Conference Call - March 31, 2015
Official Transcript                Presentation                Webcast

CytoSorbents Shareholder Update Letter - November 2014

CytoSorbents Q3 2014 Conference Call - November 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q2 2014 Conference Call  -  August 12, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q1 2014 Conference Call    -    May 14, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Fiscal 2013 Conference Call - March 31, 2014
Official Transcript                Presentation                Webcast

CytoSorbents Q3 2013 Conference Call - November 6, 2013
Official Transcript                Presentation                Webcast

CytoSorbents 2013 Shareholder Letter - January 2014

CytoSorbents Clinical and Scientific Data

CytoSorb Case Study Booklet - Nov 2015

CytoSorb Critical Care Presentation - Feb 2016

CytoSorb Critical Care Publications - Feb 2016

CytoSorb Cardiac Surgery Presentation - Feb 2016

CytoSorb Cardiac Surgery Publications - Feb 2016

HemoDefend 2015 AABB Conference Poster - Nov 2015

CytoSorbents Analyst Coverage

Zacks - CTSO: Strong Recovery in Product Sales - January 2016

Zacks - CTSO: EAP Out, IDE/PMA For Sepsis Back On The Table - December 2015

Zacks - CTSO: FDA Requests Add'l Info for EAP Designation - December 2015

Zacks - CTSO: Q3 2015 Product Sales Grow 39% - November 2015

Zacks - CTSO: $1.5M Ph2 NHLBI Grant for HemoDefend - October 2015

Zacks - CTSO: Product Sales Rebounding. Sales Force Rebuilding - August 2015

Zacks - CTSO: Q1 Inline. Continue to Expect Accelerating Growth in 2H - May 2015

Zacks - CTSO: Short-Term Hiccup. Long-Term Outlook Remains Intact - April 2015

Zacks - CTSO: FDA Greenlights U.S. Cardiac Surgery Study - Feb 2015

Zacks - CTSO: Fresenius Adds More than Just Marketing Muscle - Dec 2014

Zacks - CTSO: Data Registry, Other Developments Bode Well for Increased Adoption - Nov 2014

Zacks - CTSO: Record Product Sales, Again. Data Supports Cardiac Surgery - August 2014

Zacks - CTSO: Record Product Sales. MERS Opportunity Is Promising - May 2014

Zacks - CTSO: Record Sales in Q4 But Even Bigger Plans for 2014 - April 2014

Zacks - CTSO: Product Sales Jump, Momentum Continues - November 2013

Zacks - CTSO: Tiny Med-Tech With Huge Potential - June 2013

Zacks Small Cap Research Initiation Report Link - June 2012

Brean Murray Research Reports
Email: avogel@cytosorbents.com

H.C. Wainwright Research Reports
Email: avogel@cytosorbents.com

Merriman Research Reports
Email: avogel@cytosorbents.com

WBB Securities Research Reports
Email: avogel@cytosorbents.com


CytoSorbents Media

The Street.com Interview with Dr. Phillip Chan - December 2015

CytoSorb Therapy Testimonials - November 2015

2nd International CytoSorb Users Meeting - October 2015

What is CytoSorb? Most important facts in 5 minutes - June 2015

Medical Device Daily - Cytosorbents beats 2Q analyst forecasts, ramps up sales team

Big Days for Cytosorbents Corp (NASDAQ:CTSO) - July 2015

Medical Device Daily - CytoSorb Cardiac Trial IDE Submitted - Dec 2014

Fierce Medical Devices - Fresenius and CytoSorbents Partner - Dec 2014

Fierce Drug Delivery - CytoSorbents Uplists to NASDAQ - Dec 2014

Prince William Recognizes CytoSorbents - Dec 2014

South Brunswick Post U.S. Representative Rush Holt Visit - Jan 2014

Biotech product geared toward reducing deaths in the ICU - Jan 2014

U.S.1 News Feature - July 2013

Frost & Sullivan Report - June 2013

Wall St. Analyst Interview with Dr. Phillip Chan - May 2013

MedCity News Report - May 2013

MedGadget Interview with Dr. Chan - April 2013

Medical Device Daily Cover Story - December 2012

MoneyTV Interview with Dr. Chan - August 2012

OneMedPlace 2012 Interview with Dr. Phillip Chan

For investor relations matters or questions please contact:
avogel@cytosorbents.com

CytoSorbents Medical Inc. is a wholly owned subsidary of CytoSorbents Corporation

 

 
Home | Career Opportunities | Contact Us
© 2016 CytoSorbents Corporation All Rights Reserved